This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Chubb Limited was formerly known as ACE Limited. ACE Limited after acquiring The Chubb Corp in Jan 2016 assumed the name of Chubb. Headquartered in Zurich, Switzerland, the company boasts being one of the world’s largest providers of property and casualty (P&C) insurance and reinsurance and largest publicly traded P&C insurer, based on market capitalization of $56.9 billion. Chubb has diversified through acquisitions into many specialty lines, including marine, medical risk, excess property, environmental and terrorism insurance and has local operations in 54 countries and territories. Chubb provides specialized insurance products such as personal accident, supplemental health and life insurance to individuals in select countries. Its reinsurance operations include both P&C and life companies.
Why Chubb (CB) is a Top Value Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why You Should Hold Chubb (CB) in Your Portfolio
by Zacks Equity Research
Strong retention, new business and well-performing Life Insurance business poise Chubb (CB) well for growth.
Why Is Chubb (CB) Down 2.2% Since Last Earnings Report?
by Zacks Equity Research
Chubb (CB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Chubb Limited's (CB) Board Okays 3.6% Dividend Increase
by Zacks Equity Research
Chubb's (CB) dividend hike reflect its strong capital position. Its cash generation capabilities are supported by its underwriting and investment performance.
The Zacks Analyst Blog Highlights Broadcom, Bank of America, Thermo Fisher Scientific, Chubb Limited and Aon
by Zacks Equity Research
Broadcom, Bank of America, Thermo Fisher Scientific, Chubb Limited and Aon are part of the Zacks top Analyst Blog.
Top Stock Reports for Broadcom, Bank of America & Thermo Fisher Scientific
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Broadcom Inc. (AVGO), Bank of America (BAC) and Thermo Fisher Scientific (TMO).
A Look at Insurance ETFs Post a Mixed Bag Q1
by Sweta Killa
With the Fed slowing down the pace of rate hike and expectations of a pause in further hikes coupled with mixed results of the leading players in the industry, insurance ETFs struggled to find a footing over the last month.
ProAssurance (PRA) Incurs Q1 Loss, Revenues Down Y/Y
by Zacks Equity Research
ProAssurance's (PRA) first-quarter 2023 results grapple with lower net premiums earned and feeble underwriting results, partly offset by a fall in its total expenses.
Prudential Financial (PRU) Q1 Earnings Miss on Higher Expenses
by Zacks Equity Research
Prudential Financial's (PRU) Q1 results reflect poor performance across all segments and rising total expenses. Improving premiums partially offset the negatives.
American Financial (AFG) Q1 Earnings Beat, Revenues Rise Y/Y
by Zacks Equity Research
American Financial's (AFG) first-quarter results indicate higher P&C insurance net earned premiums and other income, offset by improved expenses and decreased underwriting profit in the P&C Insurance segment.
Assurant (AIZ) Q1 Earnings Top Estimates, Revenues Rise Y/Y
by Zacks Equity Research
Assurant's (AIZ) first-quarter results reflect higher net earned premiums, fees and other income and net investment income, offset by improved expenses and catastrophe events.
Everest Re (RE) Q1 Earnings Lag Estimates, Revenues Rise Y/Y
by Zacks Equity Research
Everest Re's (RE) first-quarter results reflect higher premiums across its reinsurance and insurance businesses, improved net investment income and underwriting income, partly offset by higher expenses.
Hartford Financial (HIG) Q1 Earnings Meet, Revenues Rise Y/Y
by Zacks Equity Research
Hartford Financial's (HIG) Q1 results reflect growing earned premiums within the Commercial Lines unit and lower mortality level, partly offset by elevated expenses.
AXIS Capital's (AXS) Q1 Earnings Beat, Revenues Rise Y/Y
by Zacks Equity Research
AXIS Capital's (AXS) first-quarter results reflect lower catastrophe losses, higher net investment income as well as increased underwriting income, offset by higher expenses.
Chubb's (CB) Q1 Earnings Surpass Estimates on Higher Premium
by Zacks Equity Research
Chubb's (CB) first-quarter results reflect higher premium revenue growth across all the segments, partly offset by higher catastrophe loss.
Compared to Estimates, Chubb (CB) Q1 Earnings: A Look at Key Metrics
by Zacks Equity Research
While the top- and bottom-line numbers for Chubb (CB) give a sense of how the business performed in the quarter ended March 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Chubb (CB) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Chubb (CB) delivered earnings and revenue surprises of 0.92% and 3.93%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Will Cat Loss Weigh on Cincinnati Financial (CINF) Q1 Earnings?
by Zacks Equity Research
Cincinnati Financial's (CINF) first-quarter results are likely to reflect growth initiatives, increased exposure, better pricing and increased property casualty agency offset by cat loss.
Is a Surprise Coming for Chubb (CB) This Earnings Season?
by Zacks Equity Research
Chubb (CB) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
RLI's Q1 Earnings Top, Revenues Miss, Premiums Rise Y/Y
by Zacks Equity Research
RLI's Q1 results reflect solid performance across all its segments, favorable reserve development and higher net investment income.
Will Chubb's (CB) Beat Streak Continue This Earnings Season?
by Zacks Equity Research
Chubb's (CB) first-quarter 2023 earnings are likely to have benefited from strong new business in the P&C business, increased exposure and higher reinvestment rates, offset by higher expenses.
Analysts Estimate Axis Capital (AXS) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Axis Capital (AXS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The Zacks Analyst Blog Highlights Pfizer, Accenture, Wells Fargo, Starbucks and Chubb
by Zacks Equity Research
Pfizer, Accenture, Wells Fargo, Starbucks and Chubb are part of the Zacks top Analyst Blog.
Finance Sector Scorecard and Analyst Reports for Pfizer, Accenture & Wells Fargo
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Pfizer Inc. (PFE), Accenture plc (ACN) and Wells Fargo & Company (WFC).
Chubb (CB) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Chubb (CB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.